Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Tigecycline is being developed as an agent that overcomes tetracycline-resistance mechanisms
and provides activity against emerging multi-drug resistant pathogens. The purpose of this
protocol is to determine the linkage between time related clinical measures of infection
response and time to bacterial eradication in patients with intravascular catheter infections
caused by Staphylococcus epidermidis and other coagulase negative staphylococci.